
CDMO News
Essential Pharma Acquires Renaissance, Expands Rare Disease Portfolio
Essential Pharma, an international specialty pharma group, has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd., a clinical stage pharmaceutical company focused on the development of life-changing therapies in pediatric rare disease. This acquisition adds